Quarterly and annual results disclosed under 8-K Item 2.02.
Gossamer Bio, Inc. reported the quarter ended March 31, 2024 results: net income Net loss for the quarter ended March 31, 2024, was $41.9 million, or $0.19 per share, EPS $0.19 per share.
“On May 7, 2024, Gossamer Bio, Inc. (the “Company”) issued a press release reporting its financial results for the quarter ended March 31, 2024.”
Scholar Rock Holding Corp reported the quarter ended March 31, 2024 results: revenue no revenue, net income net loss was $56.9 million or $0.59 per share, EPS $0.59 per share.
“For the quarter ended March 31, 2024, net loss was $56.9 million or $0.59 per share compared to a net loss of $39.4 million or $0.49 per share for the quarter ended March 31, 2023.”
AdaptHealth Corp. reported first quarter ended March 31, 2024 results: revenue $792.5 million, net income $2.1 million. Guidance reaffirmed.
“Net revenue was $792.5 million compared to $744.6 million, an increase of 6.4%. • Net loss attributable to AdaptHealth Corp. was $2.1 million compared to net income of $15.7 million.”
Y-mAbs Therapeutics, Inc. updated its the quarter ended March 31, 2024 guidance (reaffirmed).
“On May 7, 2024, Y-mAbs Therapeutics, Inc., announced its financial results for the quarter ended March 31, 2024.”
Doma Holdings, Inc. reported the three months ended March 31, 2024 results: revenue $66 million, net income $19 million.
“Total revenues of $66 million, down 22% versus Q4 2023”
HYCROFT MINING HOLDING CORP reported financial results for the quarter ended March 31, 2024.
“On May 7, 2024, Hycroft Mining Holding Corporation (the “Company”) issued a press release providing information about its operating and financial results for the quarter ended March 31, 2024.”
Catheter Precision, Inc. reported the quarter ended March 31, 2024 results: revenue $82 thousand, net income ($2.7) million.
“were $28 million · Total cash on position at March 31, 2024 was $1.5 million, and $0.5 million at May 6, 2024 · Total revenues for the three months ended March 31, 2024 were $82 thousand · Shareholders’ equity as of March 31, 2024 was $18.5 million · Net loss for the quarter ended March 31, 2024 was ($2.7) million · All revenue as of March 31, 2024 resulted from”
Denali Therapeutics Inc. reported the first quarter ended March 31, 2024 results: revenue There was no collaboration revenue for the quarter ended March 31, 2024, compared to $35.1 million for the quarter ended, net income Net loss was $101.8 million for the quarter ended March 31, 2024, compared to net loss of $109.8 million for the quarter.
“Net loss was $101.8 million for the quarter ended March 31, 2024, compared to net loss of $109.8 million for the quarter ended March 31, 2023. There was no collaboration revenue for the quarter ended March 31, 2024, compared to $35.1 million for the quarter ended March 31, 2023.”
Reddit, Inc. reported the quarter ended March 31, 2024 results: revenue $243.0 million, net income ($575.1) million.
“EX-99.1 (EX-99.1) --- Reddit Announces First Quarter 2024 Results Record user traffic, Daily Active Uniques (“DAUq”) increased 37% to 82.7 million Revenue increased 48% to $243.0 million, nearly doubling growth rate from prior quarter Net loss driven by IPO expenses, first profitable Q1 on an Adjusted EBITDA basis Operating cash flow of $32.1 million and positive”
Liberty Latin America Ltd. reported financial results for Q1 2024.
“Liberty Latin America Ltd. (“Liberty Latin America” or “LLA”) (NASDAQ: LILA and LILAK, OTC Link: LILAB) today announced its financial and operating results for the three months (“Q1”) ended March 31, 2024.”
Core Natural Resources, Inc. reported the period ended March 31, 2024 results: revenue $565.0 million, net income $101.9 million, EPS $3.39.
“by operating activities of $77.5 million; • Quarterly free cash flow 1 of $41.3 million, which was impacted by working capital changes; • Total revenue and other income of $565.0 million; • Pennsylvania Mining Complex (PAMC) produced 6.5 million tons, despite three longwall moves; • Itmann Mining Complex sold 193 thousand tons compared to 159 thousand tons during”
Hamilton Beach Brands Holding Co reported first quarter ended March 31, 2024 results: revenue $128.3 million, net income Net loss was $1.2 million, or $0.08 per diluted share, EPS $0.08 per diluted share. Guidance reaffirmed.
“23.4 % 16.3 % Operating profit (loss) $ (0.9) $ (5.1) Cash flow from operating activities $ 19.7 $ 34.9 Total debt $ 50.0 $ 79.3 Net debt $ 23.7 $ 77.1 • Total revenue of $128.3 million was flat to a year ago • Gross profit margin improved 710 basis points to 23.4% compared to 16.3% • Operating loss was $0.9 million versus a loss of $5.1 million a year ago •”
Virgin Galactic Holdings, Inc reported financial results for first quarter ended March 31, 2024.
“On May 7, 2024, Virgin Galactic Holdings, Inc. (the “Company”) issued a press release announcing certain financial and other results for the fiscal quarter ended March 31, 2024.”
Angi Inc. reported Q1 2024 results: revenue $305.4, net income Net loss (1.6), EPS $(0.00) per diluted share.
“available on the Investor Relations section of IAC’s website at ir.iac.com . ANGI INC. SUMMARY RESULTS ($ in millions except per share amounts) Q1 2024 Q1 2023 Growth Revenue $ 305.4 $ 355.5 -14 % Operating income (loss) 2.7 (10.9) NM Net loss (1.6) (15.3) 89 % Diluted (loss) per share (0.00) (0.03) 89 % Adjusted EBITDA 36.0 29.7 21 % See reconciliations of”
Granite Point Mortgage Trust Inc. reported the fiscal quarter ended March 31, 2024 results: net income $(77.7) million, EPS $(1.53) per basic share.
“Granite Point Mortgage Trust Inc. Reports First Quarter 2024 Financial Results”
AbCellera Biologics Inc. reported quarter ended March 31, 2024 results: revenue $10.0 million, net income Net loss of $40.6 million, EPS $(0.14) per share.
“● Revenue – Total revenue was $10.0 million, compared to $12.2 million in Q1 2023. Partnerships generated research fees of $9.8 million, compared to $10.6 million in Q1 2023. Licensing revenue was $0.2 million. ● Research & Development (R&D) Expenses – R&D expenses were $39.3 million, compared to $52.6 million in Q1 2023, reflecting underlying continued growth in program execution, platform development, and investments in internal programs, partially offset by the non-recurrence of specific one-time investments in co-development and internal programs. ● Sales & Marketing (S&M) Expenses – S&M expenses were $3.4 million, compared to $3.8 million in Q1 2023. ● General & Administrative (G&A) Expenses – G&A expenses were $17.4 million, compared to $15.1 million in Q1 2023. ● Net Loss – Net loss of $40.6 million, or $(0.14) per share on a basic and diluted basis, compared to net loss of $40.1 million, or $(0.14) per share on a basic and diluted basis in Q1 2023.”
WideOpenWest, Inc. reported the first quarter ended March 31, 2024 results: revenue $161.5 million, net income $15.0 million.
“First Quarter 2024 Highlights (1) ● Total Revenue of $161.5 million, a decrease of $10.7 million, or 6.2%, compared to the first quarter of 2023 ● HSD Revenue totaled $106.2 million, an increase of $1.0 million, or 1.0%, compared to the first quarter of 2023 ● Net Loss was $15.0 million for the quarter ended March 31, 2024”
Confluent, Inc. reported fiscal year 2024 results: revenue $957 million, EPS $0.19 to $0.20.
“For fiscal year 2024, Confluent expects: • Total revenue of approximately $957 million • Subscription revenue of approximately $910 million • Non-GAAP operating margin of approximately 0% • Non-GAAP net income per diluted share between $0.19 to $0.20”
Confluent, Inc. reported second quarter of 2024 results: revenue $229 million and $230 million, EPS $0.04 to $0.05.
“For the second quarter of 2024, Confluent expects: • Total revenue between $229 million and $230 million • Subscription revenue between $217 million to $218 million • Non-GAAP operating margin of approximately negative 1% • Non-GAAP net income per diluted share between $0.04 to $0.05”
Confluent, Inc. reported Q1 2024 results: EPS $0.05.
“This puts us in a stronger position to drive durable and efficient growth in the years ahead.” First Quarter 2024 Financial Highlights (In millions, except per share data and percentages) Q1 2024 Q1 2023 Y/Y Change Total Revenue $217.2 $174.3 25% Subscription Revenue $206.9 $160.6 29% GAAP Operating Loss $(111.4) $(166.1) $54.7 Non-GAAP Operating Loss $(3.3) $(40.3) $37.0 GAAP Operating Margin (51.3%) (95.3%) 44.0 pts Non-GAAP Operating Margin (1.5%) (23.1%) 21.6 pts GAAP Net Loss Per Share $(0.30) $(0.52) $0.22 Non-GAAP Net Income (Loss) Per Diluted Share $0.05 $(0.09) $0.14 Net Cash Used in Operating Activities $(26.0) $(77.8) $51.8 Free Cash Flow $(31.7) $(82.9) $51.2 Financial Outlook As previously announced, Confluent will be transitioning its revenue outlook from total revenue to subscription revenue.”
Confluent, Inc. reported first quarter of 2024, ended March 31, 2024 results: revenue $217.2.
“and efficient growth in the years ahead.” First Quarter 2024 Financial Highlights (In millions, except per share data and percentages) Q1 2024 Q1 2023 Y/Y Change Total Revenue $217.2 $174.3 25% Subscription Revenue $206.9 $160.6 29% GAAP Operating Loss $(111.4) $(166.1) $54.7 Non-GAAP Operating Loss $(3.3) $(40.3) $37.0 GAAP Operating Margin (51.3%) (95.3%)”
Ranger Energy Services, Inc. reported first quarter ended March 31, 2024 results: revenue $136.9 million, net income $0.8 million loss, EPS negative $0.03 per fully diluted share.
“Ranger Energy Services, Inc. Announces Q1 2024 Results HOUSTON, TX--(May 7, 2024) - Ranger Energy Services, Inc. (NYSE: RNGR) (“Ranger” or the “Company”) announced today its results for the first quarter ended March 31, 2024 . First Quarter 2024 Highlights – Revenue of $136.9 million, a 13% decrease from $157.5 million in first quarter 2023 driven by declines in wireline completions and ancillary services – High specification rig revenue of $79.7 million, a 3% increase from $77.5 million in first quarter 2023 with additional growth anticipated in future quarters – Net loss of $0.8 million, or negative $0.03 per fully diluted share, a decrease from net income of $6.2 million, or $0.25 per share in first quarter of 2023”
Magnolia Oil & Gas Corp reported first quarter of 2024 results: net income $97.6 million, EPS $0.46 per diluted share.
“Magnolia Oil & Gas Corporation (“Magnolia,” “we,” “our,” or the “Company”) (NYSE: MGY) today announced its financial and operational results for the first quarter of 2024.”
Delek US Holdings, Inc. reported the quarter ended March 31, 2024 results: net income Net loss of $32.6 million, EPS $(0.51) per share.
“On May 7, 2024, Delek US Holdings, Inc. (the “Company”) announced its financial results for the quarter ended March 31, 2024.”
Inozyme Pharma, Inc. reported the first quarter ended March 31, 2024 results: net income $23.3 million, EPS $0.38 loss per share.
“Net loss was $23.3 million, or $0.38 loss per share, for the quarter ended March 31, 2024”
Entrada Therapeutics, Inc. reported first quarter ended March 31, 2024 results: revenue $59.1 million, net income $23.5 million.
“of EEV therapeutic candidates targeting DMD and advance EEV-therapeutic candidates in indications beyond neuromuscular disease. Collaboration Revenue: Collaboration revenue was $59.1 million for the first quarter of 2024, compared to $25.3 million for the same period in 2023. The increase was primarily a result of the clinical advancement milestone achieved in the”
Brighthouse Financial, Inc. reported first quarter ended March 31, 2024 results: net income net loss available to shareholders of $519 million, or $8.22 per diluted share, EPS $8.22 per diluted share.
“The company reported a net loss available to shareholders of $519 million in the first quarter of 2024, or $8.22 per diluted share”
ICC Holdings, Inc. reported the three months ended March 31, 2024 results: net income $2,239,000, EPS $0.76 per share.
“Net earnings totaled $2,239,000 , or $0.76 per share, for the first quarter of 2024”
Prelude Therapeutics Inc reported financial results for first quarter ended March 31, 2024.
“On May 7, 2024, Prelude Therapeutics Incorporated (the "Company") issued a press release announcing its financial results for the three months ended March 31, 2024.”
IDEAYA Biosciences, Inc. reported financial results for first quarter ended March 31, 2024.
“On May 7, 2024, IDEAYA Biosciences, Inc. (the “Company”) announced its financial results for the first quarter ended March 31, 2024.”
Acushnet Holdings Corp. reported the three months ended March 31, 2024 results: revenue $707.6 million, net income $87.8 million. Guidance reaffirmed.
“filing. --- EX-99.1 (EX-99.1) --- Acushnet Holdings Corp. Announces First Quarter 2024 Financial Results First Quarter 2024 Financial Results • First quarter net sales of $707.6 million, up 3.1% year over year, up 4.0% in constant currency • First quarter net income attributable to Acushnet Holdings Corp. of $87.8 million, down 5.9% year over year • First”
Atkore Inc. reported fiscal 2024 second quarter ended March 29, 2024 results: revenue $792.9 million, net income $138.0 million, EPS $3.67. Guidance lowered.
“release is being furnished as Exhibit 99.1 and incorporated herein by reference. --- EX-99.1 (EX-99.1) --- Atkore Inc. Announces Second Quarter 2024 Results • Net sales of $792.9 million, down 11.5% versus prior year • Net income per diluted share decreased by $0.64 versus prior year to $3.67; Adjusted net income per diluted share decreased by $0.79 versus prior”
BLACKLINE, INC. reported the first quarter ended March 31, 2024 results: revenue $157.5 million, net income $10.8 million, or $0.17 per diluted share, EPS $0.17 per diluted share.
“for the Office of the CFO, ensuring our customers remain at the forefront of digital finance transformation.” First Quarter 2024 Financial Highlights Total GAAP revenues of $157.5 million, an increase of 13% compared to the first quarter of 2023. GAAP operating margin of 1.1%, compared to (11.0)% in the first quarter of 2023. Non-GAAP operating margin of 17.0%,”
Bioventus Inc. reported full-year 2024 results: revenue $535 million to $550 million, EPS $0.25 to $0.33. Guidance raised.
“Based on strong execution and significant momentum across the business, Bioventus is raising financial guidance for full-year 2024. The Company now expects: • Net sales of $535 million to $550 million—An increase of $15 million from previous guidance • Adjusted EBITDA* of $94 million to $99 million—An increase of $5 million from previous guidance • Non-GAAP EPS* of $0.25 to $0.33—An increase of $0.13 from previous guidance”
Bioventus Inc. reported three months ended March 30, 2024 results: revenue $129.5 million, net income net loss from continuing operations of $6.0 million, EPS Loss per share of Class A common stock from continuing operations was $0.07.
“For the first quarter, worldwide revenue totaled $129.5 million, an increase of 8.7% compared to the prior-year period. On an organic* basis, revenue increased 15.3%, driven by growth in Pain Treatments and Surgical Solutions. The Company also reported a first quarter net loss from continuing operations of $6.0 million, compared to a net loss from continuing operations of $100.0 million in the prior-year period. Adjusted EBITDA* from continuing operations totaled $22.6 million, advancing 33.5%, compared to the prior year total of $17.0 million due to strong revenue growth and increased gross margin. Loss per share of Class A common stock from continuing operations was $0.07 in the first quarter, compared to a loss of $1.28 in the prior-year period.”
Permian Resources Corp updated its first quarter of 2024 guidance (raised).
“Permian Resources Corporation (the "Company" or "Permian Resources") issued a press release announcing its financial and operational results for the first quarter of 2024.”
ARVINAS, INC. reported financial results for the first quarter ended March 31, 2024.
“On May 7, 2024 , Arvinas, Inc. announced its financial results for the quarter ended March 31, 2024 and provided a corporate update.”
Red Rock Resorts, Inc. reported first quarter ended March 31, 2024 results: revenue 488.9, net income 78.4.
“Red Rock Resorts, Inc. (“Red Rock Resorts,” “we” or the “Company”) (NASDAQ: RRR) today reported financial results for the first quarter ended March 31, 2024.”
Runway Growth Finance Corp. reported the first quarter ended March 31, 2024 results: revenue $40.0 million, net income $18.7 million, EPS $0.46 per share.
“Total investment income of $40.0 million • Net investment income of $18.7 million, or $0.46 per share”
ICHOR HOLDINGS, LTD. reported second quarter 2024 results: revenue $190 million to $205 million, EPS $(0.22) to $(0.10) GAAP diluted EPS. Guidance initiated.
“For the second quarter of 2024, we expect revenue to be in the range of $190 million to $205 million. We expect GAAP diluted EPS to be in the range of $(0.22) to $(0.10) and non-GAAP diluted EPS to be in the range of $(0.03) to $0.09.”
ICHOR HOLDINGS, LTD. reported first quarter 2024 results: revenue $201 million, net income $(8,989), EPS $(0.30).
“fluid delivery subsystems and components for semiconductor capital equipment, today announced first quarter 2024 financial results. First quarter 2024 highlights: • Revenues of $201 million; • Gross margin of 11.4% on a GAAP basis and 12.2% on a non‐GAAP basis; • Earnings per share ("EPS") of $(0.30) on a GAAP basis and $(0.09) on a non-GAAP basis; and • $117”
Toast, Inc. reported the first quarter ended March 31, 2024 results: net income $(83) million.
“Toast, Inc. announced its financial results for the fiscal quarter ended March 31, 2024”
RHYTHM PHARMACEUTICALS, INC. reported for the quarter ended March 31, 2024 results: revenue $26.0 million.
“Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update -- First quarter 2024 net revenue from global sales of IMCIVREE ® (setmelanotide) of $26.0 million -- -- On track to submit sNDA to the FDA to treat pediatric patients between 2 and younger than 6 years old in approved indications in second quarter of 2024 -- -- Phase 3 trial”
Clipper Realty Inc. reported the three months ended March 31, 2024 results: revenue $35.8 million, net income net loss of $2.7 million, EPS $0.09 per share.
“today announced financial and operating results for the three months ended March 31, 2024. Highlights for the Three Months Ended March 31, 2024 ● Record quarterly revenues of $35.8 million for the first quarter of 2024 ● Quarterly income from operations of $9.1 million for the first quarter of 2024 ● Record net operating income (“NOI”) 1 of $20.2 million for the”
Upstart Holdings, Inc. reported the second quarter of 2024 and the second half of 2024 results: revenue $125 million (Q2 2024) and $300 million (H2 2024 revenue from fees), net income $(75) million (Q2 2024). Guidance initiated.
“For the second quarter of 2024, Upstart expects: • Revenue of approximately $125 million ◦ Revenue From Fees of approximately $135 million ◦ Net Interest Income (Loss) of approximately $(10) million • Contribution Margin of approximately 56% • Net Income (Loss) of approximately $(75) million • Adjusted Net Income (Loss) of approximately $(36) million • Adjusted EBITDA of approximately $(25) million • Basic Weighted-Average Share Count of approximately 88.4 million shares • Diluted Weighted-Average Share Count of approximately 88.4 million shares For the second half of 2024, Upstart expects: • Revenue from fees of approximately $300 million, and • Positive EBITDA in the fourth quarter”
Upstart Holdings, Inc. reported the fiscal quarter ended March 31, 2024 results: revenue $128 million, net income $(64.6) million, EPS $(0.74) per diluted share.
“second half of the year and positive EBITDA by the end of the year, even in the current credit environment.” First Quarter 2024 Financial Highlights • Revenue. Total revenue was $128 million, an increase of 24% from the first quarter of 2023, but down 9% sequentially. Total fee revenue was $138 million, an increase of 18% year-over-year. • Transaction Volume and”
RMR GROUP INC. reported financial results for second fiscal quarter ended March 31, 2024.
“The RMR Group Inc. (Nasdaq: RMR) today announced its financial results for the fiscal quarter ended March 31, 2024”
Purple Innovation, Inc. reported the first quarter ended March 31, 2024 results: revenue $120.0 million, net income $(50.2) million.
“first quarter ended March 31, 2024, which were in line with guidance. First Quarter Financial Summary (Comparisons versus First Quarter 2023) 1 ● Net revenue increased 12.5% to $120.0 million compared to $106.7 million. o Wholesale revenue increased 33.1% and Direct-to-Consumer (DTC) revenue was consistent with the year ago period. ● Gross margin was 34.8% compared to”
Onterris, Inc. reported the first quarter ended March 31, 2024 results: revenue $155.3 million, net income $13.4 million, EPS $0.53. Guidance reaffirmed.
“reference in such filing. --- EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 MONTROSE ENVIRONMENTAL GROUP ANNOUNCES FIRST QUARTER 2024 RESULTS - Record First Quarter Revenue of $155.3 Million, up 18% Year-Over-Year - - Net Loss of $13.4 million; Basic and Diluted Net Loss Per Share of $0.53 - - Record First Quarter Consolidated Adjusted EBITDA 1 of $16.9 Million - -”
CPI Card Group Inc. reported first quarter ended March 31, 2024 results: revenue $111.9 million, net income $5.5 million, EPS $0.46 diluted earnings per share.
“Release is attached hereto as Exhibit 99.1. --- EX-99.1 (EX-99.1) --- CPI Card Group Inc. Reports First Quarter 2024 Results Date: May 7, 2024 Net Sales Decreased 7% to $112 Million; Net Income Decreased 50% to $5 Million; Adjusted EBITDA Decreased 8% to $23 Million Net Sales, Net Income, and Adjusted EBITDA Increased from Fourth Quarter Levels Company”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.